HuGE Literature Finder
Records 1-3
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.
Leukemia 2016 Jul . Jawhar M, Schwaab J, Hausmann D, Clemens J, Naumann N, Henzler T, Horny H-P, Sotlar K, Schoenberg S O, Cross N C P, Fabarius A, Hofmann W-K, Valent P, Metzgeroth G, Reiter |
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
Blood 2014 Apr 123 (14): 2157-60. Guglielmelli Paola, Biamonte Flavia, Rotunno Giada, Artusi Valentina, Artuso Lucia, Bernardis Isabella, Tenedini Elena, Pieri Lisa, Paoli Chiara, Mannarelli Carmela, Fjerza Rajmonda, Rumi Elisa, Stalbovskaya Viktoriya, Squires Matthew, Cazzola Mario, Manfredini Rossella, Harrison Claire, Tagliafico Enrico, Vannucchi Alessandro M, , |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: